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Highlights
 UVA irradiation causes immediate increases in cytosolic and mitochondrial Fe(II) in human dermal 
fibroblasts and endothelial cells, as monitored by Fe(II) reporters FeRhonox1 and MitoFerroGreen. 
 UVA irradiation increases dermal endothelial H2O2, monitored using the adenovirus vector Hyper-
DAAO-NES.
 UVA-dependent increases in Fe(II) and H2O2 are inhibited by ZnCl2 (10 µM) via ferritin’s 3-fold iron 
conducting channels.
 Quercetin reduces UVA dependent Fe(II) signals and H2O2 production.
 Inhibition of superoxide dismutase and catalase by tetrathiomolybdate  and 3-amino-1, 2, 4-triazole  
increases and prolongs the cytosolic Fe(II) signal after UVA irradiation. 




UVA irradiation of human dermal fibroblasts and endothelial cells induces an immediate transient increase in 
cytosolic Fe(II), as monitored by the fluorescence Fe(II) reporters, FeRhonox1 in cytosol and MitoFerroGreen 
in mitochondria. Both superoxide dismutase (SOD) inhibition by tetrathiomolybdate (ATM) and catalase 
inhibition by 3-amino-1, 2, 4-triazole (ATZ) increase and prolong the cytosolic Fe(II) signal after UVA 
irradiation.  SOD inhibition with ATM also increases mitochondrial Fe(II). Thus, mitochondria do not source 
the UV-dependent increase in cytosolic Fe(II), but instead reflect and amplify raised cytosolic labile Fe(II) 
concentration.  Hence control of cytosolic ferritin iron release is key to preventing UVA-induced 
inflammation.  UVA irradiation also increases dermal endothelial cell H2O2, as monitored by the adenovirus 
vector Hyper-DAAO-NES(HyPer). These UVA-dependent changes in intracellular Fe(II) and H2O2 are mirrored 
by increases in cell superoxide, monitored with the luminescence probe L-012. UV-dependent increases in 
cytosolic Fe(II), H2O2 and L-012 chemiluminescence are prevented by ZnCl2 (10 µM), an effective inhibitor of 
Fe(II) transport via ferritin’s 3-fold channels. Quercetin (10 µM), a potent membrane permeable Fe(II) 
chelator, abolishes the cytosolic UVA-dependent FeRhonox1, Fe(II) and HyPer, H2O2 and increase in 
MitoFerroGreen Fe(II)  signals.  The time course of the quercetin-dependent decrease in endothelial H2O2 
correlates with the decrease in FeRhox1 signal and both signals are fully suppressed by preloading cells with 
ZnCl2.  These results confirm that antioxidant enzyme activity is the key factor in controlling intracellular iron 
levels, and hence maintenance of cell antioxidant capacity is vitally important in prevention of inflammation 
initiated by labile iron and UVA. 
List of abbreviations: 3-amino-1, 2, 4-triazole (ATZ); dihydroriboflavin 5’-phosphate (FMNH2); Labile iron 
pool, (LIP); riboflavin nucleotide, FMN; degrees of freedom, d.f.; Desferrioxamine, DFO; Polyethylene 
glycolated superoxide dismutase, PEG-SOD; photon, hν; normal human dermal fibroblasts, NHDF; superoxide 
dismutase (SOD); tetrathiomolybdate (ATM) ; HBSS, Hank’s buffered saline solution 
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Introduction 
To date the individual roles of subcellular components to cytosolic UVA-dependent iron increase have been 
difficult to resolve, as temporal and spatial resolutions of iron reporters following changes in labile iron pool 
have been insufficient [1,2]; e.g. radioactive 59Fe label distribution [3] and turn-off reporters of cytosolic iron 
such as calcein [4] or PhenGreen-SK [5]. The newly available cytosolic ferrous iron sensitive turn-on 
fluorescent probes (FeRhonox1) [6] and mitochondrial Fe(II) (MitoFerroGreen) [7] potentially improve both 
the time resolution and reliability of observed changes in cytosolic and mitochondrial labile iron pool (LIP) 
following UVA irradiation. Use of these probes allows rapid monitoring of the effects of UVA irradiation on 
intracellular iron mobilization.  This can be readily sourced to ferritin, as iron diffusion through ferritin’s shell  
hydrophilic 3-fold pores is specifically inhibited by Zn(II), which binds with high affinity to sites within the 
pore  [8–11]. 
The availability of specific mitochondrial Fe(II) reporters [12–16] has shown that labile Fe(II) exists within the 
mitochondrial space at higher concentrations, around 5-7 μM, than in the cytosol with much higher 
concentrations reported in Friedrich’s ataxia ≈ 15μM) [13]. This high concentration of labile iron results 
mainly from the large negative mitochondrial membrane potential ≈-250 mV [17]. Thus, mitochondria in 
Friedrich’s ataxia or iron overload are particularly vulnerable to UVA irradiation-induced damage, as 
corroborated by the observation that mitochondrial iron chelators reduce UV-induced apoptosis [12,13,18]. 
Although iron is present is substantial amounts in mitochondria, it is unlikely to be present in dermal 
mitochondrial ferritin [19] unlike its presence in brain,  testis [19] and heart  [20]. Instead, it is likely to be 
present in dermal mitochondria and iron-sulphur clusters which are essential components both in heme 
synthesis and regulation of aconitase [21]. 
Nevertheless, given the mitochondrial high iron concentration and the large numbers of mitochondria [16], 
amounting to 20-25% of cell iron [22], it seems likely that they are a  source of the increase in cytosolic Fe(II) 
following UVA-irradiation.  Whether mitochondria are a major source of raised dermal cytosolic labile Fe(II) 
following UVA irradiation remains an unanswered question. Thus, examination of the effect of UVA on the 
subsequent intramitochondrial Fe(II) generated signal with the MitoFeGreen Fe(II) probe is of considerable 
interest [7]. 
 Another  favoured hypothesis for the source of raised intracellular labile iron following UVA irradiation is 
that ferritin iron is recycled following lysosomal damage due to excess H2O2 and UVA irradiation, [23,24].  
These challenges produce similar lytic effects on lysosomes to those from superoxide and hydroxyl radicals 
generated by cytosolic Fenton reactions and redox cycling [4,25]. Furthermore, release of lysosomal 
contents leads to mitochondrial damage [26] and can be prevented by the iron chelator desferrioxamine  
(DFO) [1].  
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In vitro, H2O2 inhibits iron release from ferritin [9,27], because it changes ferritin iron from the reduced 
ferrous Fe(II) to the oxidized ferric Fe(III) state [8]. However, exogenously sourced H2O2 has variable effects 
on cytosolic labile iron, e.g. in J16 Jurkat cells cytosolic iron is increased but unaffected in HJ16 cells [4].  
Increased calcein-chelatable iron and lysosomal destabilization by exogenous H2O2 was prevented by DFO 
[4]. The ratio of extracellular to intracellular H2O2 is estimated to be  approximately 100:1 [28]. Thus, 
apparently iron facilitates superoxide and other radical product formation from H2O2, e.g. ascorbate free 
radical and  FMN-, as a result of antioxidant enzyme activity and redox cycling reactions [29–31].
Singlet oxygen, 1O2  formed during exposure of dermal photosensitizers to UVA, may be another source of 
radical formation [32–35].  Similar difficulties have arisen in characterizing the role of H2O2 in photochemical 
activation of oxidative damage to membrane lipids and DNA, since UVA activation is known to result in iron 
release and subsequent oxidation of membrane lipids [29,36–40].  
To elucidate the roles of iron and individual reactive oxygen species in inflammatory processes initiated by 
UVA irradiation or exogenous H2O2, we examined time-dependent changes in intracellular labile iron Fe(II), 
H2O2 and superoxide before and after varying UVA irradiation doses in human dermal fibroblasts and 
endothelial cells. Additionally, we investigated the effects antioxidant enzymes superoxide dismutase and 
catalase on UVA-dependent iron mobilization by monitoring the effects of  the superoxide dismutase 
inhibitor, tetrathiomolybdate (ATM)[9,41] and catalase inhibitor aminotriazole (ATZ) [42].   
To confirm the role of ferritin in UVA-dependent Fe(II) release, we examined whether Zn (II) blocked the 
UVA-dependent release of iron into the cytosol and its effects on intracellular H2O2 and mitochondrial Fe(II) 
using the new fluorescence probe FeRhonox1 [6].  Additionally, exogenous H2O2 was added to cells to 
determine its direct effect on intracellular iron and H2O2 using reporters of both intracellular Fe(II) and H2O2  
(see Methods).  As quercetin has both high membrane permeability and high affinity for Fe(II) [43], both Zn 
(10 μM) and quercetin (10 µM)  were used to  reverse the UVA-dependent increase in FeRhonox1, and 
thereby confirm the efficacy of the switch-on Fe(II) reporters and prevention of Fe(II)-dependent increase in 
H2O2 and superoxide formation. 
Methods
Cell culture. Normal human dermal fibroblasts (NHDFs) were cultured in phenol red-free Dulbecco’s 
modified Eagles Medium (DMEM) (Sigma), supplemented with 10% foetal bovine serum (FBS), 4mM L-
glutamine (Sigma) and 1% penicillin/streptomycin (Sigma) under standard conditions (37℃, 5% CO2). Human 
dermal blood endothelial cells (HDBECs) (PromoCell, Germany) were grown in MV2 basal growth media 
(PromoCell, Germany) supplemented with 5% FBS, endothelial cell supplement kit (PromoCell, Germany) and 
1% penicillin/streptomycin under standard conditions (37℃, 5% CO2). Cells were cultured in black 96-well 
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plates for fluorescent plate-reader assays and white 96-well plates (Greiner Bio-One, Austria) for 
luminescence experiments. Treatments consisted of 4-10 μM ZnCl2, 500U/ml superoxide dismutase-
polyethylene glycol (pSOD), catalase-polyethylene glycol (pCAT), 4μM ammonium tetrathiomolybdate 
(ATM/SODinh) and 2mM 3-amino-1 2 4-triazole (3-ATZ/CATinh) added 30 min prior to experiments.   
UVA treatment. Cells were exposed to UVA (365nm) for 1-10 min (approx. 0.8-8 kJ/m2) using a UVL-56 lamp 
(UVP) in an incubator under standard conditions (37 ℃, 5% CO2).
Monitoring cytoplasmic labile iron with a selective Fe(II) probe FeRhoNox1. Measurement of intracellular 
UV-induced iron release was monitored using FeRhoNox-1, an intracellular fluorescent probe specific for the 
detection of labile iron Fe(II) [6].  Normal human dermal fibroblasts (NDHFs) were grown to confluence in 96 
well plates in DMEM and, when stated, supplemented with 0, 10 or 40M of zinc (ZnCl2). Cells were 
incubated with 5μM FeRhoNox1 (Goryo Chemical, Japan) for 1 h prior to assays, before washing twice with 
PBS followed by addition of Hank's Balanced Saline Solution (HBSS) (Gibco) containing stated treatments and 
incubated for 20 min before an assay.
Cell in microtiter plates were placed in a CLARIOstar plate-reader (BMG LabTech) which maintains a defined 
atmosphere (5% CO2, 37C). Fluorescent readings (Ex.535nm/Em.569nm) were obtained at 1 min intervals. A 
baseline reading was established for 20 min before the plate was removed to an incubator of the same 
atmospheric conditions, and the wells exposed to UVA light (360nm, 0.8-8 kJ/m2) for 1, 5 or 10 min.  The 
plate was then returned to the plate-reader for further readings.
Monitoring mitochondrial labile iron with a selective mitochondrial Fe(II) probe MitoFerroGreen.    
MitoFerroGreen is a fluorescent probe specific for the detection of Fe (II) in the mitochondria [7]. Cells were 
incubated with 5μM MitoFerroGreen (Dojindo, Japan) for 1 h prior to assays, before being washed twice and 
the addition of HBSS. (Gibco). Where stated, treatments were added to HBSS and cells incubated for 20 min 
prior to assay. Fluorescent readings (Ex/Em 505/535nm) were taken at 1 min intervals using the CLARIOstar 
plate reader (BMG Labtech). For UVA treatment, the plate was removed to an incubator of the same 
atmospheric conditions and the wells exposed to UVA light (360nm) for 1, 5 or 10 min (0.8-8 kJ/m2).  The 
plate was then returned to the plate-reader for further readings.
Reactive oxygen species generation. Cells were incubated with the chemiluminescent probe L012 (10μM) in 
HBSS. Chemiluminescence was measured in a CLARIOstar plate reader at 1 min intervals according to 
methods reported previously [44]. 
Monitoring intracellular hydrogen peroxide with the molecular probe HyPer using a multiwell plate reader. 
Cells were transfected with HyPer-DAAO-NES (HyPer) adenovirus vector (D-amino acid oxidase-nuclear 
export signal) (kindly provided by Professor Thomas Michel, Harvard University) at a multiplicity of infection 
(MOI) of 300. After 24 h of incubation, cells were washed three times with PBS and grown for a further 48 h 
before experimentation. Fluorescent readings were taken in HBSS and where stated, treatments were added 
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to cells then incubated for 20 min prior to assay. HyPer ratiometric fluorescent signals were acquired using 
the CLARIOstar plate reader (BMG LabTech) at 1 min intervals. These fluorescent signals are reported as a 
ratio of Ex 490/420 Em 520nm.  The advantage of HyPer is that it is a dynamic reversible probe for 
intracellular H2O2 and has many advantages over other fluorescent probes that are generally irreversible and 
hence unsuited to monitoring dynamic changes in H2O2[45,46] .  
Results
UVA irradiation increases skin fibroblast cytosolic chelatable iron
Once FeRhonox1 was loaded and the fluorescence output equilibrated, as judged by the output from the 
Clariostar plate reader, the plate was exposed to UVA for varying times outside the platereader and then 
replaced immediately.  The break in the output reading is shown in Figure 1A, which shows a typical readout 
of FeRhonox1 signals in normal human dermal fibroblasts (NDHF) exposed for 5 min to UVA irradiation (4 
kJ/m2). Immediately after UVA irradiation, there is a sharp increase in the FeRhonox1 fluorescence (P < 
0.001), that is increased by longer irradiation (not shown).  The increase in FeRhonox1 signal is enhanced 
when the SOD inhibitor ATM is present. Application of ZnCl2 (10 µM) prior to UVA irradiation prevents the 
UVA-dependent increase in FeRhonox1 signal (P < 0.001) (Figures 1A, 1B). Zn is effective in inhibiting iron 
mobilization over a range of UVA irradiation form 1-10 min (0.8-8 kJ/m2). These findings provide useful 
confirmation that the most likely source of iron for the UV-dependent increase in cytosolic iron is likely to be 
cytosolic ferritin. Low concentrations of Zn have been shown to block ascorbate and iron-dependent ferritin 
iron mobilization in ferritin solutions, [9].   
Figure 2A show a typical averaged readout of FeRhonox1 signals plotted as a histogram in fibroblast control 
cells (prior to UVA irradiation) and after 1 and 5 min UVA irradiation (0.8 and 4 kJ/m2). The increment in 
FeRhonox1 signal is enhanced by longer irradiation times. In unirradiated cells, the superoxide dismutase 
inhibitor, ammonium tetrathiomolybdate (4 M ATM)[47], decreased the steady state FeRhonox1 signal, as 
did the catalase inhibitor 3-amino-1, 2, 4-triazole (3-ATZ/CATinh). However, following UVA irradiation, both 
ATM (Figure 2B ) and ATZ increased the cellular FeRhonox1 response to UVA irradiation. 
The raised increase in FeRhonox1 signal after UVA irradiation, which is mainly dependent upon cell  
superoxide dismutate inhibition, supports the view that superoxide induces iron mobilization  [27,48] and 
hence increases the labile iron pool. These results indicate that UVA irradiated control skin fibroblasts are 
normally protected from excessive increases in cytosolic Fe(II) from UVA mobilized iron by the action of 
antioxidant enzymes  superoxide dismutase and catalase, and probably also glutathione peroxidase [49], 
which separately and together prevent superoxide formation and hence retard superoxide-dependent iron 
mobilization from ferritin.   
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The effect of a catalase inhibitor ATZ on the UVA-dependent increment in FeRhonox1 (Figure 2B) suggests 
that UVA-dependent increases in intracellular H2O2 also cause an increase in the labile iron pool.  This is likely 
to be due to H2O2 formation as a result of superoxide dismutase activity.  As already demonstrated in Figures 
1A and 1B, exposure to low concentrations of ZnCl2 prevents UV-dependent iron release in dermal 
fibroblasts and endothelial cells, suggesting that the bulk of the increase in cytosolic Fe(II) following UVA 
irradiation stems from ferritin iron mobilisation. 
Effect of UVA irradiation on intracellular H2O2 in dermal endothelial cells monitored by HyPer fluorescence  
As stated in the Methods, intracellular H2O2 was monitored with the aid of adenovirus vector Hyper-DAAO-
NES transfection into dermal endothelial cells.  Although fibroblasts show a small HyPer response, the signal 
to noise ratio in these cells is too large to give reliably significant results. As HyPer transfected dermal 
endothelial cells show significant responses to UVA and exogenous H2O2, all subsequent experiments using 
HyPer were conducted with dermal endothelial cells. Notably, dermal endothelial cells take up more 
FeRhonox1 than fibroblasts and therefore exhibit a larger response to UVA.    
Effect of exogenous H2O2 on intracellular FeRhonox1 signal in dermal endothelial cells and fibroblasts.   
An increased HyPer H2O2 signal following addition of exogenous H2O2 (100 μM) confirms that the HyPer 
probe acts as an effective probe for intracellular H2O2.  However, the effect is relatively short-lived (4-10 
min) (Figure 3A).  The duration of the H2O2 transient is prolonged with exposure to higher H2O2 
concentrations and by inhibition of SOD. Addition of exogenous H2O2 (100 μM) to dermal endothelial cells 
results in a transient increase in FeRhonox1 signal (Figure 3B). These findings support the view that the co-
presence of superoxide and H2O2 amplify ferritin iron mobilization (not shown in this Figure).  
 The time course of the decrease from the peak signal closely matches the decrease from peak signal 
obtained with H2O2 in endothelial cells transfected with HyPer (Figure 3A). This finding corroborates a recent 
report [4], showing an increase in labile iron pool following Jurkat cell exposure to varying concentrations of 
exogenous H2O2.  
Effects of UVA exposure on cytosolic H2O2 in dermal endothelial cells
HyPer responses were monitored in endothelial cells in the absence prior to or after UVA exposure.  
Averaged signals are shown in Figure 4A and after 5 min UVA irradiation the intracellular HyPer signal 
increases  by 2-fold (P <  0.01) and in the presence of a SOD inhibitor (20 μM ATM) by > 3-fold  (P < 0.001). 
This can be compared with the response to exogenous H2O2 (100 μM) which increases the HyPer response 
2.5-fold (P< 0.001).  The likely source of this extra superoxide particularly with Fe(II) enriched cytosol is from 
iron catalysed  Fenton reaction [50]. 
In dermal endothelial cells, as in fibroblasts, similar qualitative effects of the SOD inhibitor ATM are observed 
for iron release. Thus, it is evident that intrinsic antioxidant SOD activity normally prevents significant net 
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iron mobilization from ferritin. This finding implies that a major cause of UVA-dependent iron release to the 
cytosol results from superoxide anion formation, a known source of electrons which reduces ferritin core 
Fe(III) to soluble, mobile and chelatable Fe(II), [48,51]. In addition to raising dermal endothelial H2O2, SOD 
inhibition by ATM (4 μM) increases the FeRhonox1 signal after 5 min UVA irradiation (P < 0.001) (Figure 3). 
Effect of quercetin on FeRhonox1 signals and intracellular HyPer in dermal endothelial cells  
Quercetin (10 μM) was added to the dermal endothelial bathing solution 100 min after UVA exposure, to 
determine the reversibility of the FeRhonox1 response to raised intracellular Fe(II) and of HyPer to raised 
H2O2.  Quercetin at concentrations in excess of labile iron,  acts as a very high affinity Fe(II) chelator 
[43,52,53]. Quercetin reduces both dermal fibroblast and endothelial cell FeRhonox1 signals (t1/2 ≈ 7 min) 
(Figure 4B and S1). The quercetin-dependent decrease in FeRhonox1 signal is significantly larger after 
exposing the cells to inhibitors of catalase and superoxide dismutase (Supplemental Figures S1B and S1C). 
This larger decrement in intracellular Fe(II) after quercetin chelation is consistent with the raised intracellular 
iron concentration, as has already been shown following exposure to antioxidant enzyme inhibitors (Figures 
2B and 4B). 
Quercetin also rapidly reduces the intracellular HyPer signal observed after UV irradiation of dermal 
endothelial cells (Figure 4C). This finding signifies that iron chelation reduces reactive oxygen species 
production, and hence the redox cycling of these products with consequent reduction in intracellular H2O2 
concentration.  These latter results all point to a positive correlation between intracellular H2O2 and labile 
iron pool levels and corroborate the findings of Qenaei et al [4]. However, our results with cultured dermal 
endothelial cells are dissimilar to the observed effects of H2O2 on ferritin in solution  [9,27]. Addition of H2O2 
to ferritin solutions strongly inhibits ascorbate-dependent iron mobilization.  It is likely that the net effect of 
either addition of exogenous H2O2 or direct generation of intracellular H2O2 with raised labile iron, is to 
catalyse electrons production of electrons  that reduce Fe(III) and thereby further increase labile cytosolic 
Fe(II) by  redox cycling of iron and superoxide, H2O2 and hydroxyl radicals[54]. 
Evidence of increased reactive oxygen luminescence following UVA irradiation in dermal fibroblasts 
Use of luminescence reporters, such as L-012, provide useful corroboration that UVA enhances intracellular 
free radical production involving oxygen species (Supplemental Figure S2). It is evident that UVA enhances 
luminescence, although longer irradiation times reduced the signal.  It is also apparent, from the 
luminescence enhancement observed with PEG-catalase and PEG-SOD, that L012 is responding primarily to 
cytosolic superoxide signals. The significant reduction in luminence with quercetin corroborates previous 
findings showing that quercetin is an effective quencher of free radicals and Fe(II) chelator [52,55,56]. 
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Effect of UVA irradiation on mitochondrial labile iron in dermal endothelial cells
As already mentioned, mitochondria have a very high iron concentration, amounting to approximately 20-
25% of total cell iron [22,57,58]. Thus, mitochondria are a plausible source of the increase in cytosolic Fe(II) 
following UVA-irradiation. To ascertain whether this is the case, we examined the effects of UVA on 
mitochondrial Fe(II) using the mitochondrial Fe(II) reporter MitoFerroGreen (see Methods).  Following UVA 
irradiation of dermal endothelial cells, an increase mitochondrial iron is observed. Additionally, intra-
mitochondrial labile iron signal is further increased in cells treated with SOD inhibitor ATM (4 μM) (Figure 5).  
 SOD inhibition increases UVA-dependent mitochondrial labile iron increase in dermal fibroblasts
Although both dermal fibroblasts and endothelial cells respond in similar ways to UV with respect to ferritin 
dependent iron release, we further compared the effects of UVA on mitochondrial labile iron signals in 
dermal fibroblasts loaded either with FeRhonox1 or MitoFerroGreen to compare UV induced changes in 
cytosolic and mitochondrial iron in the same cell preparation at the same time.  
Normal dermal fibroblasts were treated with PEG-SOD (500U/ml) and SOD inhibitor ATM (4µM), before 
exposure to UVA for 1, 5 and 10 min (0.8-8 kJ/m2). Labile iron in the mitochondria was measured using the 
MitoFerroGreen fluorescent probe.  As with UVA effects on cytosolic Fe(II) reported by FeRhonox1, when 
ZnCl2  is applied prior to UVA it prevents the increase in mitochondrial Fe(II) (Figure 5A). Moreover, following 
addition of quercetin(10 µM), there is a rapid decline in mitochondrial Fe(II), suggesting that mitochondrial 
iron levels change in parallel with cytosolic iron (Figure 5B).
Zinc reduces the basal level of mitochondrial iron
As shown in Figures 5B and Supplemental Figure S3, treatment of dermal fibroblasts with the SOD inhibitor 
ATM (4µM) and zinc chloride (40M) lead to increases in labile iron in the mitochondria. Since there is no 
evidence of any immediate UVA dependent decrease in mitochondrial Fe(II) signal, evidently the rise is 
cytosolic Fe(II) following UVA irradiation cannot be sourced from mitochondria.  
Discussion 
The novel findings in this study are that UVA irradiation of dermal fibroblasts and endothelial cells leads to 
mobilization of ferritin iron and a subsequent rise in cytosolic Fe(II) and H2O2 and mitochondrial Fe(II).  These 
increases are normally masked by intracellular antioxidant enzyme activities, namely superoxide dismutase 
and catalase, which when inhibited lead to enhanced and prolonged rises in cytosolic and mitochondrial 
Fe(II) and H2O2 and superoxide activities.  Much of the variability reported previously in cellular responses to 
UVA may now be assigned to variable amounts of ferritin iron and variable activities of antioxidant enzymes 
[4]. Previous work has shown that exposure of dermal fibroblasts to UVA (0-12 J/cm2) [59,60] results in 
partial  inactivation of antioxidant enzymes catalase and superoxide dismutase, although glutathione 
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peroxidase and glutathione reductase activities were unaffected.  Thus much of  the increased sensitivity of 
aging skin to UV may also be ascribed to variability in these factors [61,62]. 
The underlying processes of photolytic and ligand induced iron release from ferritin [63,64] are very similar 
to those well described in other ferrihydrites, such as goethite and magnetite [65–69]. In brief, 
photoactivation of the surface iron-hydroxo complexes with siderophoric ligands, such as citric or ascorbic 
acid, leads to charge transfer to the mineral surface Fe (III) to produce Fe (II) and subsequent release of 
soluble ferrous ion and production of hydroxyl, and superoxide free radicals in a series of cyclic reactions 
(see Eq 1-3 and Graphical Abstract).
Eq 1 [Fe(III)(OH)2+]+ hϑ →Fe(II)+ ∙HO
Eq 2 [Fe(III)(citrate)]+ hϑ →Fe(II) +citrate2∙- 
Eq 3 citrate2∙- +O2 → oxidation products + CO2 + O2∙-
Thus in oxygenated ferrihydrite solutions, UVA irradiation leads to both hydroxyl and superoxide radical 
production and in the presence of ascorbate [70] and or citrate  [71,72] either long lived ascorbate or 
shorter-lived citrate radicals. These can transfer electrons to Fe(III) with release of soluble Fe(II) from the 
metal oxide surface.  This applies both to geological ferrihydrites and to the biological ferritin ferrihydrite 
core.   
Fe(III) dissolution is stimulated by an Fe(II) chelator which reduces the local Fe(II) activity and thereby 
prevents or retards Fe(II) reoxidation at the ferroxidase site and hence greatly accelerates net Fe(II) release 
to the aqueous environment [73]. It is evident from this model that intracellular photolytic reactions depend 
largely on the availability of Fe(III) sites at the exposed aqueous interface. Both ferritin and hemosiderin are 
considered to be the major cytosolic targets, although recent Mossbauer spectroscopy studies suggest that 
much hemosiderin may be produced as a post-mortem artefact [74,75]. 
Mitochondria are another possible photolytic target, as they contain relatively high concentrations of labile 
Fe (II) (15 μM) [13,76,77]. Whether this high concentration of labile iron exists within mitochondria in vivo 
remains a debated question. It seems likely that the Fe(III)/Fe(II) ratio is  altered by Fe(II) chelators.  
Mossbauer spectroscopic studies, which do not depend on chelators to report iron concentrations, suggest 
that much of the mitochondrial iron exists as low mass Fe(III) complexes that are precursors for Fe/S cluster 
formation [74,75,78,79]. Thus, UV irradiation could lead to an acute increase in mitochondrial Fe(II) as a 
result of reduction of Fe(III)/S clusters to Fe(II) and consequent electron leakage from mitochondrial complex 
II [80].   The finding that Zn exposure prior to UV irradiation reduces mitochondrial Fe(II) (Figure 5A) appears 
to confound this hypothesis.  However, there is a small UVA-dependent increase in mitochondrial Fe(II) in 
zinc treated- dermal endothelial cells which is further enhanced in the presence of the SOD inhibitor ATM 
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(Figure 5A). These latter findings suggest that stored mitochondrial Fe(III) is converted to Fe(II) by raised 
intramitochondrial superoxide following UV irradiation.     
Increased intracellular iron raises the intracellular rates of H2O2 production (Figure S1A), and conversely 
reducing cytosolic chelatable iron with quercetin reduces levels of cytosolic H2O2. The observed correlations 
between intracellular H2O2, superoxide and Fe(II) (Figure S1A) in the same endothelial cell preparation, and 
between quercetin-dependent changes in FeRhonox1 signal and quercetin-dependent decreases in Hyper,  
FeRhonox1 and L-012 signals, indicate that there is a positive feedback between production of superoxide 
and hydroxyl radicals and iron release. The results in Figure 5 indicate that cytosolic iron rapidly equilibrates 
between the cytosol and mitochondrial spaces since Zn, which inhibits Fe(II) efflux from ferritin, reduces 
both cytosolic and mitochondrial Fe(II). Moreover, quercetin, which also rapidly reduces cytosolic Fe(II) 
activity, also reduces mitochondrial Fe(II).  
There are several possible routes of mitochondrial iron uptake;  DMT1, a di-metal ion proton cotransporter, 
present in the outer mitochondrial membrane [81,82] and mitoferrins 1 and 2 present in the inner 
membrane [15,83]. Additionally, the mitochondrial calcium uniporter (MCU)[84] mediates rapid iron uptake 
and, most likely, the rapid Fe(II)  exit we have observed after exposure of dermal endothelial cell to  
quercetin (Figure 5). 
Mitochondria may also accumulate iron as a result of defective iron export. The ABCB7/8 transporters are 
known to be mitochondrial Fe(II) exporters. Overexpression of ABCB8 transporter protects against 
ferroptosis [85,86] and impairs cardiomyocyte damage caused by the chemotherapeutic drug doxorubicin a 
known inhibitor of ABCB8 activity [87–89].  Although, currently whether any dermal cell mitochondrial ABCB 
type transporters are altered during the aging process it is unknown; nevertheless,  it is known that aging in 
dermal cells results in low level of inflammation [90]. Since dermal inflammation leads to increased hepcidin 
secretion, which suppresses the iron export transporter ferroportin [91], this could be an explanation for cell 
iron accumulation in senescent skin.  
Senescent skin cells,  may be particularly susceptible to photolytic damage, as they accumulate large 
amounts of ferritin iron, possibly resulting from glutathione depletion, leading to impaired ferroptosis [92–
94].  Thus, curtailing excessive iron uptake, with topical applications of quercetin [95] or catechins, which 
have similarly high iron binding affinity  [43]  together with zinc salts [61]  as illustrated in this study, may 
help to ameliorate some of the senolytic dermal degeneration. Topical application of polyphenols has 
frequently been recommended as antiaging in cosmetic preparations and apparently polyphenols seem to 
have some ameliorative actions in vivo [96]. The current study would suggest that much of the UVA 
dependent skin pathology can be ameliorated by prevention or reduction in exposure to a raised dermal 
labile iron pool. 
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Conclusions and clinical perspectives
Identification of ferritin as the key intracellular source of the UVA-dependent iron release is important, as it 
can be blocked by Zn(II) and reduced by the chelating effects of membrane permeable flavanols, such as 
quercetin or catechins present in green tea [25,53] and thereby attenuate labile iron accumulation. 
Additionally, more traditional anti-inflammatory drugs such as dexamethasone,  which upregulate neutrophil 
gelatinase associated lipocalin NGAL and protect  against oxidative stress by sequestering siderophores[97], 
may add to the efficacy of these anti-ageing therapies. 
Acknowledgements
This work was supported by Unilever (Dr Richard Siow, Dr Mark Fowler) and Heart Research UK (Ref. No. 
RG2672, Prof GE Mann). The authors are grateful to Professor Thomas Michel, Harvard University who kindly 
provided the HyPer-DAAO-NES (HyPer) adenovirus vector.  The authors are very grateful to Prof Giovanni E, 
Mann (School of Cardiovascular Medicine & Sciences, King’s College London) for his useful advice, 
encouragement and support during the preparation of this paper. 
Authors Contributions  
MJS and RJN designed the experiments, MJS conducted all cell cultures and experimentation, RJN 
and MJS analysed the data and wrote the text and constructed the figures.  MJS, MF, RCMS and RJN 
discussed and revised the paper. 
14
References
[1] C. Pourzand, R.D. Watkin, J.E. Brown, R.M. Tyrrell, Ultraviolet A radiation induces immediate 
release of iron in human primary skin fibroblasts: the role of ferritin., Proc. Natl. Acad. Sci. U. 
S. A. 96 (1999) 6751–6756. doi:10.1073/pnas.96.12.6751.
[2] J.L. Zhong, A. Yiakouvaki, P. Holley, R.M. Tyrrell, C. Pourzand, Susceptibility of skin cells to 
UVA-induced necrotic cell death reflects the intracellular level of labile iron, J. Invest. 
Dermatol. 123 (2004) 771–780. doi:10.1111/j.0022-202X.2004.23419.x.
[3] S. Roberts, A. Bomford, Ferritin iron kinetics and protein turnover in K562 cells, J. Biol. Chem. 
263 (1988) 19181–19187.
[4] A. Al-Qenaei, A. Yiakouvaki, O. Reelfs, P. Santambrogio, S. Levi, N.D. Hall, R.M. Tyrrell, C. 
Pourzand, Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of 
chronically adapted Jurkat T cells to hydrogen peroxide, Free Radic. Biol. Med. 68 (2014) 87–
100. doi:10.1016/j.freeradbiomed.2013.12.006.
[5] T. Hirayama, H. Tsuboi, M. Niwa, A. Miki, S. Kadota, Y. Ikeshita, K. Okuda, H. Nagasawa, A 
universal fluorogenic switch for Fe( II) ion based on N-oxide chemistry permits the 
visualization of intracellular redox equilibrium shift towards labile iron in hypoxic tumor cells, 
Chem. Sci. 8 (2017) 4858–4866. doi:10.1039/C6SC05457A.
[6] T. Mukaide, Y. Hattori, N. Misawa, S. Funahashi, L. Jiang, T. Hirayama, H. Nagasawa, S. 
Toyokuni, Histological detection of catalytic ferrous iron with the selective turn-on 
fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model, Free 
Radic. Res. 48 (2014) 990–995. doi:10.3109/10715762.2014.898844.
[7] T. Hirayama, A. Miki, H. Nagasawa, Organelle-specific analysis of labile Fe(ii) during 
ferroptosis by using a cocktail of various colour organelle-targeted fluorescent probes, 
Metallomics. 11 (2019) 111–117. doi:10.1039/c8mt00212f.
[8] X. Yang, P. Arosio, N.D. Chasteen, Molecular diffusion into ferritin: pathways, temperature 
dependence, incubation time, and concentration effects., Biophys. J. 78 (2000) 2049–2059. 
doi:10.1016/S0006-3495(00)76752-X.
[9] C. Badu-Boateng, S. Pardalaki, C. Wolf, S. Lajnef, F. Peyrot, R.J. Naftalin, Labile Iron 
Potentiates Ascorbate-Dependent Reduction and Mobilization of Ferritin iron, Free Radic. 
Biol. Med. 108 (2017) 94–109. doi:10.1016/j.freeradbiomed.2017.03.015.
15
[10] K. Zeth, Dps biomineralizing proteins: multifunctional architects of nature., Biochem. J. 445 
(2012) 297–311. doi:10.1042/BJ20120514.
[11] G. Zhao, F. Bou-Abdallah, P. Arosio, S. Levi, C. Janus-Chandler, N.D. Chasteen, Multiple 
pathways for mineral core formation in mammalian apoferritin. The role of hydrogen 
peroxide., Biochemistry. 42 (2003) 3142–50. doi:10.1021/bi027357v.
[12] O. Reelfs, V. Abbate, R.C. Hider, C. Pourzand, A Powerful Mitochondria-Targeted Iron 
Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation, J. Invest. 
Dermatol. 136 (2016) 1692–1700. doi:10.1016/j.jid.2016.03.041.
[13] O. Reelfs, V. Abbate, A. Cilibrizzi, M.A. Pook, R.C. Hider, C. Pourzand, The role of 
mitochondrial labile iron in Friedreich’s ataxia skin fibroblasts sensitivity to ultraviolet A, 
Metallomics. 11 (2019) 656–665. doi:10.1039/c8mt00257f.
[14] Y. Ma, V. Abbate, R.C. Hider, Iron-sensitive fluorescent probes: Monitoring intracellular iron 
pools, Metallomics. 7 (2015) 212–222. doi:10.1039/c4mt00214h.
[15] H. Lv, P. Shang, The significance, trafficking and determination of labile iron in cytosol, 
mitochondria and lysosomes, Metallomics. 10 (2018) 899–916. doi:10.1039/c8mt00048d.
[16] F. Petrat, H. De Groot, U. Rauen, Subcellular distribution of chelatable iron: A laser scanning 
microscopic study in isolated hepatocytes and liver endothelial cells, Biochem. J. 356 (2001) 
61–69. doi:10.1042/0264-6021:3560061.
[17] M. Niwa, T. Hirayama, I. Oomoto, D.O. Wang, H. Nagasawa, Fe(II) Ion Release during 
Endocytotic Uptake of Iron Visualized by a Membrane-Anchoring Fe(II) Fluorescent Probe, 
ACS Chem. Biol. (2018) acschembio.7b00939. doi:10.1021/acschembio.7b00939.
[18] C.K. Lim, D.S. Kalinowski, D.R. Richardson, Protection against hydrogen peroxide-mediated 
cytotoxicity in Friedreich’s ataxia fibroblasts using novel iron chelators of the 2-
pyridylcarboxaldehyde isonicotinoyl hydrazone class, Mol. Pharmacol. 74 (2008) 225–235. 
doi:10.1124/mol.108.046847.
[19] H. Yang, M. Yang, H. Guan, Z. Liu, S. Zhao, S. Takeuchi, D. Yanagisawa, I. Tooyama, 
Mitochondrial ferritin in neurodegenerative diseases, Neurosci. Res. 77 (2013) 1–7. 
doi:10.1016/j.neures.2013.07.005.
[20] X. Li, P. Wang, Q. Wu, L. Xie, Y. Cui, H. Li, P. Yu, Y.Z. Chang, The construction and 
16
characterization of mitochondrial ferritin overexpressing mice, Int. J. Mol. Sci. 18 (2017). 
doi:10.3390/ijms18071518.
[21] T.A. Rouault, N. Maio, Biogenesis and Functions of Mammalian Iron-Sulfur Proteins in the 
Regulation of Iron Homeostasis and Pivotal Metabolic Pathways, J. Biol. Chem. 292 (2017) 
jbc.R117.789537. doi:10.1074/jbc.R117.789537.
[22] V.S. Richmond, M. Worwood, A. Jacobs, The Iron Content of Intestinal Epithelial Cells and Its 
Subcellular Distribution: Studies on Normal, Iron‐Overloaded and Iron‐Deficient Rats, Br. J. 
Haematol. 23 (1972) 605–614. doi:10.1111/j.1365-2141.1972.tb07095.x.
[23] D.C. Radisky, J. Kaplan, Iron in cytosolic ferritin can be recycled through lysosomal 
degradation in human fibroblasts., Biochem. J. 336 ( Pt 1 (1998) 201–5. 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1219858&tool=pmcentrez&ren
dertype=abstract.
[24] K. Ollinger, U.L.F.T. Brunk, Cellular injury Induced by oxidative stress is mediated through 
lysosomal damage., Free Radic. Biol. Med. 19 (1995) 565–574.
[25] S. Basu-Modak, D. Ali, M. Gordon, T. Polte, A. Yiakouvaki, C. Pourzand, C. Rice-Evans, R.M. 
Tyrrell, Suppression of UVA-mediated release of labile iron by epicatechin-A link to lysosomal 
protection, Free Radic. Biol. Med. 41 (2006) 1197–1204. 
doi:10.1016/j.freeradbiomed.2006.06.008.
[26] M. Tenopoulou, P.-T. Doulias, A. Barbouti, U. Brunk, D. Galaris, Role of compartmentalized 
redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis., Biochem. J. 387 
(2005) 703–710. doi:10.1042/BJ20041650.
[27] R.F. Boyer, C.J. McCleary, Superoxide ion as a primary reductant in ascorbate-mediated 
ferritin iron release., Free Radic. Biol. Med. 3 (1987) 389–95. 
http://www.ncbi.nlm.nih.gov/pubmed/2828195.
[28] H. Sies, Hydrogen peroxide as a central redox signaling molecule in physiological oxidative 
stress: Oxidative eustress, Redox Biol. 11 (2017) 613–619. doi:10.1016/j.redox.2016.12.035.
[29] P. Morlière, A. Moysan, R. Santus, G. Hüppe, J.C. Mazière, L. Dubertret, UVA-induced lipid 
peroxidation in cultured human fibroblasts, Biochim. Biophys. Acta (BBA)/Lipids Lipid Metab. 
1084 (1991) 261–268. doi:10.1016/0005-2760(91)90068-S.
17
[30] A. Moysan, I. Marquis, F. Gaboriau, R. Santus, L. Dubertret, P. Morlière, Ultraviolet A – 
Induced Lipid Peroxidation and Antioxidant Defense Systems in Cultured Human Skin 
Fibroblasts, J. Invest. Dermatol. 100 (1993) 692–698. doi:10.1111/1523-1747.ep12472352.
[31] F. Funk, J.P. Lenders, R.R. Crichton, W. Schneider, Reductive mobilisation of ferritin iron., Eur. 
J. Biochem. 152 (1985) 167–72. http://www.ncbi.nlm.nih.gov/pubmed/4043077.
[32] J.L. Liu, Q. Xue, C.G. Liu, F.W. Bai, S. Wada, J.Y. Wang, Chemiluminescence imaging of UVA 
induced reactive oxygen species in mouse skin using L-012 as a probe, Free Radic. Res. 52 
(2018) 1424–1431. doi:10.1080/10715762.2018.1500019.
[33] M. Berneburg, S. Grether-Beck, V. Kürten, T. Ruzicka, K. Briviba, H. Sies, J. Krutmann, Singlet 
oxygen mediates the UVA-induced generation of the photoaging- associated mitochondrial 
common deletion, J. Biol. Chem. 274 (1999) 15345–15349. doi:10.1074/jbc.274.22.15345.
[34] K. Jomova, M. Valko, Advances in metal-induced oxidative stress and human disease., 
Toxicology. 283 (2011) 65–87. http://www.ncbi.nlm.nih.gov/pubmed/21414382 (accessed 
July 17, 2012).
[35] Z. Yang, J. Qian, A. Yu, B. Pan, Singlet oxygen mediated iron-based Fenton-like catalysis under 
nanoconfinement, Proc. Natl. Acad. Sci. U. S. A. 116 (2019) 6659–6664. 
doi:10.1073/pnas.1819382116.
[36] K. Punnonen, C.T. Jansen, A. Puntala, M. Ahotupa, Effects of in vitro UVA irradiation and 
PUVA treatment on Membrane Fatty Acidds and activities of Antioxidant Enzymes in Human 
Keratinocytes, J. Invest. Dermatol. 96 (1991) 255–259.
[37] G.F. Vile, R.M. Tyrrell, Uva radiation-induced oxidative damage to lipids and proteins in vitro 
and in human skin fibroblasts is dependent on iron and singlet oxygen, Free Radic. Biol. Med. 
18 (1995) 721–730. doi:10.1016/0891-5849(94)00192-M.
[38] M.J. Burkitt, B.C. Gilbert, Model studies of the iron-catalysed Haber-Weiss cycle and the 
ascorbate-driven Fenton reaction., Free Radic. Res. Commun. 10 (1990) 265–80. 
http://www.ncbi.nlm.nih.gov/pubmed/1963164.
[39] N.R. Perron, J.L. Brumaghim, A review of the antioxidant mechanisms of polyphenol 
compounds related to iron binding., Cell Biochem. Biophys. 53 (2009) 75–100. 
doi:10.1007/s12013-009-9043-x.
18
[40] G.R. Buettner, The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, a-
Tocopherol, and Ascorbate, Arch. Biochem. Biophys. 300 (1993) 535–543. 
doi:10.1006/abbi.1993.1074.
[41] J.C. Juarez, M. Manuia, M.E. Burnett, O. Betancourt, B. Boivin, D.E. Shaw, N.K. Tonks, A.P. 
Mazar, F. Doñate, Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation 
and inactivation of phosphatases in growth factor signaling., Proc. Natl. Acad. Sci. U. S. A. 105 
(2008) 7147–52. doi:10.1073/pnas.0709451105.
[42] P.L. Merle, C. Sabourault, S. Richier, D. Allemand, P. Furla, Catalase characterization and 
implication in bleaching of a symbiotic sea anemone, Free Radic. Biol. Med. 42 (2007) 236–
246. doi:10.1016/j.freeradbiomed.2006.10.038.
[43] E. Vlachodimitropoulou, P.A. Sharp, R.J. Naftalin, Quercetin-iron chelates are transported via 
Glucose ( GLUT ) transporters ., Free Radic. Biol. Med. 50 (2011) 934–44. 
doi:10.1016/j.freeradbiomed.2011.01.005.
[44] M. He, M. Nitti, S. Piras, A.L. Furfaro, N. Traverso, M.A. Pronzato, G.E. Mann, Heme 
oxygenase-1-derived bilirubin protects endothelial cells against high glucose-induced 
damage, Free Radic. Biol. Med. 89 (2015) 91–98. doi:10.1016/j.freeradbiomed.2015.07.151.
[45] V. V. Belousov, A.F. Fradkov, K.A. Lukyanov, D.B. Staroverov, K.S. Shakhbazov, A. V. Terskikh, 
S. Lukyanov, Genetically encoded fluorescent indicator for intracellular hydrogen peroxide, 
Nat. Methods. 3 (2006) 281–286. doi:10.1038/nmeth866.
[46] A. Hernández-Barrera, C. Quinto, E.A. Johnson, H.M. Wu, A.Y. Cheung, L. Cárdenas, Using 
hyper as a molecular probe to visualize hydrogen peroxide in living plant cells: A method with 
virtually unlimited potential in plant biology, Methods Enzymol. 527 (2013) 275–290. 
doi:10.1016/B978-0-12-405882-8.00015-5.
[47] S. Choi, S. Park, G.H. Liang, J.A. Kim, Cellular Physiology and Biochemistr y Biochemistry 
Superoxide Generated by Lysophosphatidyl- choline Induces Endothelial Nitric Oxide 
Synthase Downregulation in Human Endothelial Cells, Cell Physiol. Biochem. 25 (2010) 233–
240.
[48] P. Biemond, H. Van Eijk, A. Swaak, J. Koster, Iron Mobilization from Ferritin by Superoxide 
Derived from Stimulated polymorphonuclear Leucocytes., J Clin Invest. 73 (1984) 1576–1579.
[49] C. Michiels, O. Toussaint, J. Remacle, Importance of SE-Glutathione peroxidase, catalase, and 
19
Cu/Zn-SOD for cell survival against oxidative stress., Science (80-. ). 17 (1994) 235–248.
[50] G. Minotti, S.D. Aust, An investigation into thee mechanism of citrate-FE2+-dependent lipid 
peroxidation, Free Radic. Biol. Med. 3 (1987) 379–387. doi:10.1016/0891-5849(87)90016-5.
[51] C. Badu-Boateng, R.J. Naftalin, Ascorbate and ferritin interactions: Consequences for iron 
release in vitro and in vivo and implications for inflammation, Free Radic. Biol. Med. (2018). 
doi:10.1016/j.freeradbiomed.2018.09.041.
[52] M. Melidou, K. Riganakos, D. Galaris, Protection against nuclear DNA damage offered by 
flavonoids in cells exposed to hydrogen peroxide: the role of iron chelation., Free Radic. Biol. 
Med. 39 (2005) 1591–600. doi:10.1016/j.freeradbiomed.2005.08.009.
[53] M. Guo, C. Perez, Y. Wei, E. Rapoza, G. Su, F. Bou-Abdallah, N.D. Chasteen, Iron-binding 
properties of plant phenolics and cranberry’s bio-effects., Dalton Trans. (2007) 4951–61. 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2645657&tool=pmcentrez&ren
dertype=abstract (accessed June 10, 2011).
[54] K. Jomova, S. Baros, M. Valko, Redox active metal-induced oxidative stress in biological 
systems, Transit. Met. Chem. 37 (2012) 127–134. doi:10.1007/s11243-012-9583-6.
[55] P. Filipe, J.N. Silva, J. Haigle, J.P. Freitas, A. Fernandes, R. Santus, P. Morlière, Contrasting 
action of flavonoids on phototoxic effects induced in human skin fibroblasts by UVA alone or 
UVA plus cyamemazine, a phototoxic neuroleptic., Photochem. Photobiol. Sci. 4 (2005) 420–
428. doi:10.1039/b416811a.
[56] B.R. Zhou, H. Bin Yin, Y. Xu, D. Wu, Z.H. Zhang, Zhi-Qiang Yin, F. Permatasari, D. Luo, Baicalin 
protects human skin fi broblasts from ultraviolet A radiation-induced oxidative damage and 
apoptosis, Free Radic. Res. 46 (2012) 1458–1471. doi:10.3109/10715762.2012.726355.
[57] N.D. Jhurry, M. Chakrabarti, S.P. McCormick, G.P. Holmes-Hampton, P.A. Lindahl, Biophysical 
investigation of the ironome of human Jurkat cells and mitochondria, Biochemistry. 51 (2012) 
5276–5284. doi:10.1021/bi300382d.
[58] B.T. Paul, D. Manz, F. Torti, S. V. Torti, Mitochondria and Iron: Current Questions Bibbin, 
Expert Rev. Hematol. 10 (2016) 95–118. doi:10.1080/17474086.2016.1268047.Mitochondria.
[59] Y. Shindo, T. Hashimoto, Time course of changes in antioxidant enzymes in human skin 
fibroblasts after UVA irradiation, J. Dermatol. Sci. 14 (1997) 225–232. doi:10.1016/S0923-
20
1811(96)00578-6.
[60] S.R. Pinnell, Cutaneous photodamage, oxidative stress, and topical antioxidant protection, J. 
Am. Acad. Dermatol. 48 (2003) 1–22. doi:10.1067/mjd.2003.16.
[61] A. Kammeyer, R.M. Luiten, Oxidation events and skin aging, Ageing Res. Rev. 21 (2015) 16–
29. doi:10.1016/j.arr.2015.01.001.
[62] A. Aroun, J.L. Zhong, R.M. Tyrrell, C. Pourzand, Iron, oxidative stress and the example of solar 
ultraviolet A radiation, Photochem. Photobiol. Sci. 11 (2012) 118–134. 
doi:10.1039/c1pp05204g.
[63] J.P. Laulhère, A.M. Labouré, J.F. Briat, Photoreduction and incorporation of iron into 
ferritins., Biochem. J. 269 (1990) 79–84.
[64] J.S. Rohrer, M. Joo, E. Dartyge, D.E. Sayers, A. Fontaine, E.C. Theil, Stabilization of Iron in a 
Ferrous form by ferritin., J Biol Chem. 262 (1987) 13385–13387.
[65] Y. Zhu, R. Zhu, L. Yan, H. Fu, Y. Xi, H. Zhou, G. Zhu, J. Zhu, H. He, Visible-light 
Ag/AgBr/ferrihydrite catalyst with enhanced heterogeneous photo-Fenton reactivity via 
electron transfer from Ag/AgBr to ferrihydrite, Appl. Catal. B Environ. 239 (2018) 280–289. 
doi:10.1016/j.apcatb.2018.08.025.
[66] Z. Wang, W.D.C. Schenkeveld, S.M. Kraemer, D.E. Giammar, Synergistic Effect of Reductive 
and Ligand-Promoted Dissolution of Goethite, Environ. Sci. Technol. 49 (2015) 7236–7244. 
doi:10.1021/acs.est.5b01191.
[67] Z. Wang, H. Fu, L. Zhang, W. Song, J. Chen, Ligand-Promoted Photoreductive Dissolution of 
Goethite by Atmospheric Low-Molecular Dicarboxylates, J. Phys. Chem. A. 121 (2017) 1647–
1656. doi:10.1021/acs.jpca.6b09160.
[68] P.M. Borer, B. Sulzberger, P. Reichard, S.M. Kraemer, Effect of siderophores on the light-
induced dissolution of colloidal iron(III) (hydr)oxides, Mar. Chem. 93 (2005) 179–193. 
doi:10.1016/j.marchem.2004.08.006.
[69] P. Avetta, A. Pensato, M. Minella, M. Malandrino, V. Maurino, C. Minero, K. Hanna, D. Vione, 
Activation of persulfate by irradiated magnetite: Implications for the degradation of phenol 
under heterogeneous photo-fenton-like conditions, Environ. Sci. Technol. 49 (2015) 1043–
1050. doi:10.1021/es503741d.
21
[70] J. Du, J.J. Cullen, G.R. Buettner, Ascorbic acid: Chemistry, biology and the treatment of 
cancer., Biochim. Biophys. Acta. 1826 (2012) 443–57. 
http://www.ncbi.nlm.nih.gov/pubmed/22728050 (accessed November 3, 2012).
[71] J. Van der Zee, K.B. BH, C.F. Chignell, T.M.A.R. Dubbelman, J. Van Steveninck, Hydroxyl radical 
generation by a light-dependent Fenton Reaction, Free Radic. Biol. Med. 14 (1993) 105–113.
[72] M. Oszajca, M. Brindell, Ł. Orzeł, J.M. Dąbrowski, K. Śpiewak, P. Łabuz, M. Pacia, A. Stochel-
Gaudyn, W. Macyk, R. van Eldik, G. Stochel, Mechanistic studies on versatile metal-assisted 
hydrogen peroxide activation processes for biomedical and environmental incentives, Coord. 
Chem. Rev. 327–328 (2016) 143–165. doi:10.1016/j.ccr.2016.05.013.
[73] J.P. Laulhère, F. Barcelò, M. Fontecave, Dynamic equilibria in iron uptake and release by 
ferritin., Biometals. 9 (1996) 303–9. http://www.ncbi.nlm.nih.gov/pubmed/8696080.
[74] S.P. McCormick, M.J. Moore, P.A. Lindahl, Detection of Labile Low-Molecular-Mass Transition 
Metal Complexes in Mitochondria, Biochemistry. 54 (2015) 3442–3453. 
doi:10.1021/bi5015437.
[75] J.D. Wofford, M. Chakrabarti, P.A. Lindahl, Mössbauer spectra of mouse hearts reveal age-
dependent changes in mitochondrial and ferritin iron levels, J. Biol. Chem. 292 (2017) 5546–
5554. doi:10.1074/jbc.M117.777201.
[76] F. Petrat, S. Paluch, E. Dogruöz, P. Dörfler, M. Kirsch, H.-G. Korth, R. Sustmann, H. de Groot, 
Reduction of Fe(III) ions complexed to physiological ligands by lipoyl dehydrogenase and 
other flavoenzymes in vitro: implications for an enzymatic reduction of Fe(III) ions of the 
labile iron pool., J. Biol. Chem. 278 (2003) 46403–13. doi:10.1074/jbc.M305291200.
[77] Z.I. Cabantchik, Labile iron in cells and body fluids: Physiology, pathology, and pharmacology, 
Front. Pharmacol. 5 MAR (2014) 1–11. doi:10.3389/fphar.2014.00045.
[78] T.A. Rouault, Iron-sulfur proteins hiding in plain sight, Nat. Chem. Biol. 11 (2015) 442–445. 
doi:10.1038/nchembio.1843.
[79] R. Garcia-Serres, M. Clémancey, J.M. Latour, G. Blondin, Contribution of Mössbauer 
spectroscopy to the investigation of Fe/S biogenesis, J. Biol. Inorg. Chem. 23 (2018) 635–644. 
doi:10.1007/s00775-018-1534-z.
[80] A. Anderson, A. Bowman, S.J. Boulton, P. Manning, M.A. Birch-Machin, A role for human 
22
mitochondrial complex II in the production of reactive oxygen species in human skin, Redox 
Biol. 2 (2014) 1016–1022. doi:10.1016/j.redox.2014.08.005.
[81] N.A. Wolff, M.D. Garrick, L. Zhao, L.M. Garrick, A.J. Ghio, F. Thévenod, A role for divalent 
metal transporter (DMT1) in mitochondrial uptake of iron and manganese, Sci. Rep. 8 (2018) 
1–12. doi:10.1038/s41598-017-18584-4.
[82] I. Yanatori, Y. Yasui, M. Tabuchi, F. Kishi, Chaperone protein involved in transmembrane 
transport of iron, Biochem. J. 462 (2014) 25–37. doi:10.1042/BJ20140225.
[83] L.R. Devireddy, D.O. Hart, D.H. Goetz, M.R. Green, A Mammalian Siderophore Synthesized by 
an Enzyme with a Bacterial Homolog Involved in Enterobactin Production, Cell. 141 (2010) 
1006–1017. http://dx.doi.org/10.1016/j.cell.2010.04.040.
[84] X. Zhang, J.J. Lemasters, Translocation of iron from lysosomes to mitochondria during 
ischemia predisposes to injury after reperfusion in rat hepatocytes, Free Radic. Biol. Med. 63 
(2013) 243–253. doi:10.1016/j.freeradbiomed.2013.05.004.
[85] H. Chang, R. Wu, M. Shang, T. Sato, C. Chen, J.S. Shapiro, T. Liu, A. Thakur, K.T. Sawicki, S.V. 
Prasad, H. Ardehali, Reduction in mitochondrial iron alleviates cardiac damage during injury, 
EMBO Mol. Med. 8 (2016) 247–267. doi:10.15252/emmm.201505748.
[86] V. Kumar, A.K. A., R. Sanawar, A. Jaleel, T.R. Santhosh Kumar, C.C. Kartha, Chronic Pressure 
Overload Results in Deficiency of Mitochondrial Membrane Transporter ABCB7 Which 
Contributes to Iron Overload, Mitochondrial Dysfunction, Metabolic Shift and Worsens 
Cardiac Function, Sci. Rep. 9 (2019) 1–16. doi:10.1038/s41598-019-49666-0.
[87] E. Cocco, V. Porrini, M. Derosas, V. Nardi, G. Biasiotto, F. Maccarinelli, I. Zanella, Protective 
effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in 
HeLa cells., Mol. Biol. Rep. (2013). doi:10.1007/s11033-013-2792-z.
[88] R. Gordan, S. Wongjaikam, J.K. Gwathmey, N. Chattipakorn, S.C. Chattipakorn, L.H. Xie, 
Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update, 
Heart Fail. Rev. 23 (2018) 801–816. doi:10.1007/s10741-018-9700-5.
[89] Y. Ichikawa, M. Ghanefar, M. Bayeva, R. Wu, A. Khechaduri, S. V. Naga Prasad, R.K. 
Mutharasan, T. Jairaj Naik, H. Ardehali, Cardiotoxicity of doxorubicin is mediated through 
mitochondrial iron accumulation, J. Clin. Invest. 124 (2014) 617–630. doi:10.1172/JCI72931.
23
[90] J.A. Wright, T. Richards, S.K.S. Srai, The role of iron in the skin and cutaneous wound healing, 
Front. Pharmacol. 5 JUL (2014) 1–8. doi:10.3389/fphar.2014.00156.
[91] E. Nemeth, Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its 
Internalization, Science (80-. ). 306 (2004) 2090–2093. doi:10.1126/science.1104742.
[92] S. Masaldan, S.A.S. Clatworthy, C. Gamell, P.M. Meggyesy, A.T. Rigopoulos, S. Haupt, Y. 
Haupt, D. Denoyer, P.A. Adlard, A.I. Bush, M.A. Cater, Iron accumulation in senescent cells is 
coupled with impaired ferritinophagy and inhibition of ferroptosis, Redox Biol. 14 (2018) 
100–115. doi:10.1016/j.redox.2017.08.015.
[93] S. Masaldan, A.I. Bush, D. Devos, A.S. Rolland, C. Moreau, Striking while the iron is hot: Iron 
metabolism and ferroptosis in neurodegeneration, Free Radic. Biol. Med. (2019). 
doi:10.1016/j.freeradbiomed.2018.09.033.
[94] Y. Sun, Y. Zheng, C. Wang, Y. Liu, Glutathione depletion induces ferroptosis, autophagy, and 
premature cell senescence in retinal pigment epithelial cells article, Cell Death Dis. 9 (2018). 
doi:10.1038/s41419-018-0794-4.
[95] S.R. Kim, K. Jiang, M. Ogrodnik, X. Chen, X.-Y. Zhu, H. Lohmeier, L. Ahmed, H. Tang, T. 
Tchkonia, L.J. Hickson, J.L. Kirkland, L.O. Lerman, Increased renal cellular senescence in 
murine high-fat diet: effect of the senolytic drug quercetin, Transl. Res. (2019) 1–12. 
doi:10.1016/j.trsl.2019.07.005.
[96] O. V. Zillich, U. Schweiggert-Weisz, P. Eisner, M. Kerscher, Polyphenols as active ingredients 
for cosmetic products, Int. J. Cosmet. Sci. 37 (2015) 455–464. doi:10.1111/ics.12218.
[97] S. Chakraborty, S. Kaur, S. Guha, S.K. Batra, The multifaceted roles of neutrophil gelatinase 
associated lipocalin (NGAL) in inflammation and cancer, Biochim. Biophys. Acta - Rev. Cancer. 
1826 (2012) 129–169. doi:10.1016/j.bbcan.2012.03.008.
24
Figures and Figure Legends:
Figure 1. Zinc protects against UVA-induced intracellular iron release in human dermal fibroblasts. (A) 
Normal human dermal fibroblasts (NHDF) were pre-treated with the SOD inhibitor ATM (4µM) with/without 
zinc (40µM) and then exposed to UVA irradiation (8 kJ/m2) for 5 min at the indicated time point. Increases 
in labile iron were measured using the FeRhoNox fluorescent probe. (B) Relative FeRhoNox-1 fluorescent 
intensity in NHDF after UVA exposure (0.8-8 kJ/m2) for 1-10 min following pre-incubation with 0, 10 or 
40M zinc. Fluorescence was measured in a CLARIOStar plate reader. Data denote mean  SEM, n=3 
independent cell cultures, *P < 0.001 vs control.
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Figure 2. SOD and catalase inhibition increases UVA-dependent labile iron increase in dermal fibroblasts. 
(A) NHDFs were pre-treated with SOD inhibitor ATM (4µM), exposed to UVA for 1 and 5 min (0.8 and 4 
kJ/m2) and labile iron measured using the FeRhoNox1 fluorescent probe (after UV versus before UVA: * 
P<0.05, **P<0.01, ***P<0.001), (after UVA versus before UVA with SOD inhibitor  ++ P < 0.01 and ++ 
P<0.001).
 (B) NHDFs were irradiated for 5 min with UVA (4 kJ/m2) and the mean difference in FeRhoNox1 signal 
measured. Pre UVA (grey bar) difference between signal at (20 min - 40 min) and black bar difference 
between after 5 min UVA irradiation (60 min - 80 min) (see time course in Figure 1A) treated with 2mM 
Catalase inhibitor 3-ATZ (CATinh) or SOD inhibitor ATM (4µM). Data denote means ± S.E.D n=3 independent 
wells,Difference between inhibited enzyme condition and control before UV (grey bars)   **P<0.01 and 
differences between  enzyme  inhibitions  after UVA irradiation  anc control after UVA irradiation (black 
columns(++P < 0.01 and +++ P<0.001).   Thus both catalase and SOD inhibition significantly increase the 
FeRohnox1 signals before UVA irradiation and after UVA irradiation. 
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Figure 3.  Treatment with exogenous hydrogen peroxide increases labile iron in dermal endothelial cells. 
(A) Dermal endothelial cells (HDBECs), transfected with the HyPer hydrogen peroxide ratiometric fluorescent 
probe, show an increase in fluorescent signal upon treatment with 100 µM exogenous H2O2, regardless of 
previous UVA irradiation. (B)  Concurrent increase in labile iron, measured using FeRhoNox fluorescent 
probe, following exogenous H2O2 treatment. Data denote mean  S.E.M., n=3 replicates.
27
Figure 4. Quercetin inhibits intracellular free iron and hydrogen peroxide in dermal endothelial cells. 
(A) HDBECs transfected with HyPer that were pre-treated with SOD inhibitor ATM (4µM)(grey bars) and 
exposed to UVA for 5 min (4 kJ/m2) show an increase in HyPer signal above control after UVA.  
Control after UV versus before UVA **P<0.01; SOD inhibitor after UV versus SOD inhibitor, before 
UVA (  +++ P<0.001) Black bars show the effects of exposure of the cell cultures to   H2O2 (50 μM) on 
the Hyper signal   after versus before H2O2 °°° P<0.001. 
(B)  Change in FeRhoNox signal in HDBECs treated with vehicle (controlor SOD inhibitor ATM (4µM) +  
2mM Catalase inhibitor (CATinh) (3-ATZ) after UVA irradiation (***P<0.001). After addition of 
quercetin (10µM) (+++ P<0.001).  Thus,  quercetin has a significantly greater effect on cells treated 
with both SOD and catalase inhibitors than controls indicating a higher level of labile Fe(II) prior to 
quercetin treatment in cells treated with antioxidant inhibitors.  
(C) Change in HyPer signal in HDBECs treated with quercetin (10µM) and irradiated with UVA for 5 min 
(4 kJ/m2). Data denote mean ± S.E.M., n=3 independent cultures,  + P < 0.05 difference between 
before and after UVA (control); **P<0.01, difference between before and after UVA (quercetin ) ;  
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Figure 5. Mitochondrial iron levels change in parallel to cytosolic iron levels in dermal fibroblasts.
 (A) NHDFs were treated with SOD inhibitor ATM (4μM) or pegSOD (500U/ml), exposed to UVA for 1 -10 min 
(0.8-8 kJ/m2) and labile iron in the mitochondria measured using MitoFerroGreen fluorescent probe and 
expressed as relative fluorescence (arbitrary units)  ** P < 0.01 column condition versus control ( no UVA  
column 1).  ++ P < 0.01, column condition versus SOD inhibition, (no UVA, column 2). 
 (B) NHDFs were treated with SOD inhibitor ATM (4μM) and ZnCl2 (10μM) before being exposed to UVA (4 
kJ/m2) and labile iron in the mitochondria measured using MitoFerroGreen fluorescent probe. Condition 
versus control no UV (column 1) *P<0.05.  
(C) Change in MitoFerroGreen signal in HDBECs pre-treated with pegSOD (500U/ml) before treatment ± 
quercetin (10µM) and irradiated with UVA for 5 min (4 kJ/m2)., *P<0.05, Condition relative to control no 
UVA column 1 ***P<0.001 Condition with quercetin and UVA  relative to beforeUVA irradiation. .Data 
denote mean ± S.E.M., n=3 independent cultures .  
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Supplementary Figure S1A.  Correlation between the changes in intracellular Fe(II)  reported by FeRhonox1 
(x axis) and H2O2 reported by HyPer signals (y axis)  following addition of quercetin (10 𝛍M) to dermal 
endothelial cells incubated with the SOD inhibitor  ATM  (4 𝛍M). Data denote means ± S.E.M of Hyper 
signals, Pearson’s correlation coefficient of the best fit linear correlation fit   is=0.64 (d.f. 28, p < 0.001).  
Supplementary Figure S1B                                                                     Supplementary Figure S1C           
Supplementary Figures S1B and S1C. Output signals showing the time courses of effects of quercetin (10 
𝛍M) addition to cell cultures post UVA exposure on FeRhonox1 and MitoFeGreen fluorescence. Figure S1B 
shows a more gradual and smaller percentage decrease in cytosolic Fe(II) than observed with mitochondrial 
Fe(II) as reported by MitoFeGreen in Figure S1C.
                                                                                          
S1B Quercetin reduces cell FeRhonox1 signal after UVA 10 min by 40%  
t1/2 ≈ 7 min. Quercetin reduces MitoFeGreen signal after UVA 10 min by   
65%  t1/2 ≈ 3 min.  No effect of UVA  without UVA. 
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Supplementary Figure S2. Reactive oxygen species detected by L012 are induced by UVA, increased by 
catalase and reduced by iron chelation with quercetin. NHDFs were treated with pegSOD (500U/ml), SOD 
inhibitor ATM (4µM), catalase inhibitor 3-AT (2mM) and Quercetin (10µM) with UVA irradiation of 1-10 min 
(0.8-8 kJ/m2). Mean luminescence signal of intracellular reactive oxygen species was measured using the 
chemiluminescent probe L012. Catalase increases this signal, (P <0.01), whilst quercetin reduces the signal. 
Data denote mean  S.E.M. (P <0.001), n=3-5 replicates.  
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Supplementary Figure S3. Zinc inhibits changes in mitochondrial iron levels following UVA irradiation of 
dermal fibroblasts. NHDFs were treated with vehicle (DMSO) (Control) or SOD inhibitor ATM (4uM), with or 
without Zinc (10µM) and exposed to UVA for 10 min (8 kJ/m2) and labile iron in the mitochondria measured 
using MitoFerroGreen fluorescent probe. Data denote mean ± S.E.M., n=3 independent cultures, P<0.05.
